| Unitedhealth Group Incorporated | 93,600 | US$38.9M | 3.7% |
| Cvs Health Corporation | 279K | US$28.9M | 2.7% |
| Merck & Company, Inc. | 214K | US$27.4M | 2.6% |
| Eli Lilly And Company | 22,315 | US$26.8M | 2.5% |
| Abbvie Inc. | 96,775 | US$24.4M | 2.3% |
| Alignment Healthcare, Inc. | 997K | US$23.7M | 2.2% |
| Edwards Lifesciences Corporation | 260K | US$23.5M | 2.2% |
| Gilead Sciences, Inc. | 178K | US$22.5M | 2.1% |
| Biogen Inc. | 94,850 | US$20.5M | 1.9% |
| Stryker Corporation | 65,000 | US$20.5M | 1.9% |
| Boston Scientific Corporation | 451K | US$19.2M | 1.8% |
| Johnson & Johnson | 72,500 | US$18.4M | 1.7% |
| Guardant Health, Inc. | 115K | US$17.3M | 1.6% |
| Regeneron Pharmaceuticals, Inc. | 27,390 | US$17.1M | 1.6% |
| Glaukos Corporation | 119K | US$16.6M | 1.6% |
| Biomarin Pharmaceutical Inc. | 291K | US$16.6M | 1.6% |
| Nurix Therapeutics, Inc. | 684K | US$16.6M | 1.6% |
| Natera, Inc. | 61,050 | US$16.6M | 1.6% |
| Mirum Pharmaceuticals, Inc. | 139K | US$16.3M | 1.5% |
| Insmed Incorporated | 152K | US$16.2M | 1.5% |
| Tenet Healthcare Corporation | 85,200 | US$15.9M | 1.5% |
| Thermo Fisher Scientific Inc | 31,580 | US$15.8M | 1.5% |
| Centene Corporation | 244K | US$15.7M | 1.5% |
| Axsome Therapeutics, Inc. | 63,050 | US$15.4M | 1.5% |
| Danaher Corporation | 80,252 | US$15.3M | 1.4% |
| Vertex Pharmaceuticals Incorporated | 30,685 | US$15.2M | 1.4% |
| Anteris Technologies Global Corp. | 1.54M | US$15.2M | 1.4% |
| Neurocrine Biosciences, Inc. | 85,841 | US$14.5M | 1.4% |
| The Pennant Group, Inc. | 371K | US$13.7M | 1.3% |
| Intuitive Surgical, Inc. | 34,500 | US$13.7M | 1.3% |
| Elevance Health, Inc. | 34,900 | US$13.5M | 1.3% |
| Cencora, Inc. | 46,778 | US$13.2M | 1.2% |
| Charles River Laboratories International, Inc. | 57,200 | US$13M | 1.2% |
| Ideaya Biosciences, Inc. | 344K | US$12.8M | 1.2% |
| Mckesson Corporation | 16,550 | US$12.5M | 1.2% |
| Syndax Pharmaceuticals, Inc. | 560K | US$12.2M | 1.2% |
| Brightspring Health Services, Inc. | 166K | US$11.6M | 1.1% |
| Mineralys Therapeutics, Inc. | 416K | US$11.2M | 1.1% |
| Oscar Health, Inc. | 392K | US$11.2M | 1.1% |
| Dexcom, Inc. | 160K | US$10.8M | 1.0% |
| Align Technology, Inc. | 63,000 | US$10.6M | 1.0% |
| Spyre Therapeutics, Inc. | 119K | US$10.6M | 1.00% |
| Relay Therapeutics, Inc. | 566K | US$10.6M | 1.00% |
| Arrowhead Pharmaceuticals, Inc. | 128K | US$10.4M | 0.98% |
| Agilent Technologies, Inc. | 75,000 | US$9.96M | 0.94% |
| Nektar Therapeutics | 141K | US$9.86M | 0.93% |
| Abbott Laboratories | 96,000 | US$8.71M | 0.82% |
| Dianthus Therapeutics, Inc. | 86,127 | US$8.4M | 0.79% |
| Procept Biorobotics Corporation | 345K | US$7.79M | 0.74% |
| Oruka Therapeutics, Inc. | 80,000 | US$7.61M | 0.72% |
| Encompass Health Corporation | 74,263 | US$7.51M | 0.71% |
| Iovance Biotherapeutics, Inc. | 1.71M | US$7.09M | 0.67% |
| Bridgebio Pharma, Inc. | 91,100 | US$6.79M | 0.64% |
| Kura Oncology, Inc. | 592K | US$6.49M | 0.61% |
| Insulet Corporation | 42,000 | US$6.39M | 0.60% |
| Erasca, Inc. | 349K | US$6.39M | 0.60% |
| Krystal Biotech, Inc. | 16,325 | US$6.07M | 0.57% |
| Astrana Health Inc. | 119K | US$5.52M | 0.52% |
| Cardinal Health, Inc. | 22,500 | US$5.35M | 0.50% |
| Alnylam Pharmaceuticals, Inc. | 17,200 | US$5.18M | 0.49% |
| Molina Healthcare Inc | 21,857 | US$5M | 0.47% |
| Viking Therapeutics, Inc. | 128K | US$4.99M | 0.47% |
| The Cigna Group | 17,400 | US$4.8M | 0.45% |
| Ionis Pharmaceuticals, Inc. | 59,900 | US$4.75M | 0.45% |
| Amn Healthcare Services Inc | 144K | US$4.68M | 0.44% |
| Denali Therapeutics Inc. | 179K | US$4.6M | 0.43% |
| Medpace Holdings, Inc. | 8,500 | US$4.5M | 0.42% |
| Madrigal Pharmaceuticals, Inc. | 8,050 | US$4.32M | 0.41% |
| Amgen Inc. | 11,900 | US$4.31M | 0.41% |
| Sionna Therapeutics, Inc. | 97,100 | US$4.27M | 0.40% |
| The Cooper Companies, Inc. | 54,000 | US$3.87M | 0.37% |
| Waystar Holding Corp. | 179K | US$3.67M | 0.35% |
| Mbx Biosciences, Inc. | 62,000 | US$3.42M | 0.32% |
| Vericel Corporation | 70,000 | US$3.11M | 0.29% |
| Veeva Systems Inc. | 17,300 | US$3.07M | 0.29% |
| Bicara Therapeutics Inc. | 88,150 | US$2.62M | 0.25% |
| Ocular Therapeutix, Inc. | 225K | US$2.21M | 0.21% |
| Stoke Therapeutics, Inc. | 64,500 | US$2.11M | 0.20% |
| Xenon Pharmaceuticals Inc. | 33,250 | US$2.01M | 0.19% |
| Doximity, Inc. | 76,107 | US$1.58M | 0.15% |
| Privia Health Group, Inc. | 50,000 | US$1.29M | 0.12% |
| Minimed Group, Inc. | 55,000 | US$822K | 0.08% |
| Alphatec Holdings, Inc. | 85,000 | US$735K | 0.07% |
| Agilon Health, Inc. | 5,000 | US$536K | 0.05% |
| 10x Genomics, Inc. | 8,500 | US$326K | 0.03% |
| Tandem Diabetes Care, Inc. | 20,000 | US$302K | 0.03% |
| Tg Therapeutics, Inc. | 5,000 | US$275K | 0.03% |
| Apogee Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Ascendis Pharma A/s | 0 | US$0 | 0.00% |
| Compass Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Esperion Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Iqvia Holdings, Inc. | 0 | US$0 | 0.00% |
| Nuvalent, Inc. | 0 | US$0 | 0.00% |
| Adaptive Biotechnologies Corporation | 0 | US$0 | 0.00% |